ArticleFrontiers in medicine2026
Development and validation of a 24-h predictive model for hypertriglyceridemic moderately severe acute pancreatitis: a single-center retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a risk prediction model for identifying patients with hypertriglyceridemia-induced acute pancreatitis who are at risk of progressing to moderately severe acute pancreatitis (MSAP) within 24 h after admission, thereby providing decision support for early clinical intervention. Methods: A single-center retrospective study was conducted, enrolling 146 patients with HTG-AP admitted between January 2018 and December 2023. The patients were randomly divided into a training set and a validation set at a ratio of 7:3. Predictive factors were screened using univariate analysis and multivariate logistic regression, To address the quasi-complete separation observed in the SIRS variables, a Firth penalized likelihood logistic regression model was employed to develop the prediction model. Model discrimination was assessed using the area under the receiver operating characteristic curve (ROC-AUC). Calibration performance was evaluated using the Hosmer-Lemeshow goodness-of-fit test, calibration plots, Brier score, and calibration slope. Clinical utility was assessed through decision curve analysis (DCA). Comparative performance against the BISAP score was conducted using DeLong's test. Internal validation was performed using 1,000 bootstrap resamples to estimate and adjust for optimism bias. Results: Multivariable analysis based on Firth's penalized likelihood logistic regression showed that systemic inflammatory response syndrome (SIRS) (OR = 202.469, Conclusion: SIRS and elevated TG levels within 24 h after admission are independent predictors of progression to moderately severe disease in patients with HTG-AP. The prediction model based on these variables demonstrates good predictive performance. A 24-h TG level below 18.41 mmol/L indicates a relatively lower risk of progression to moderately severe disease; however, prediction based on combined biochemical indicators is recommended. Further studies are required to validate the effectiveness of this model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.